selected publications
-
Journal Article
- Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia. Diabetes, Obesity & Metabolism. 2021
- Reproducibility of a prediabetes classification in a contemporary population. Metabolism Open. 2020
- Establishing an electronic health record-supported approach for outreach to and recruitment of persons at high risk of type 2 diabetes in clinical trials: the vitamin D and type 2 diabetes (D2d) study experience. Clinical Trials (London, England). 2019
- Implementation of basal-bolus therapy in type 2 diabetes: a randomized controlled trial comparing bolus insulin delivery using an insulin patch with an insulin pen. Diabetes Technology & Therapeutics. 2019
- Vitamin D supplementation and prevention of type 2 diabetes. New England Journal of Medicine. 2019
- Baseline characteristics of the Vitamin D and type 2 Diabetes (D2d) study: a contemporary prediabetes cohort that will inform diabetes prevention efforts. Diabetes care. 2018
- Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. Diabetes, Obesity & Metabolism. 2017
- Efficacy and safety of LixiLan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes inadequately controlled on basal insulin and metformin: The LixiLan-L randomized trial. Diabetes care. 2016
-
Conference Poster
-
Abstract